search

1-20 of 33

Save search

Sort by

Sort Order Select

Journal Article

P311 Intensive dried blood spot sampling shows a higher drug exposure throughout the first 24 weeks of therapy in ustekinumab-treated Crohn’s disease patients achieving endoscopic remission

PDF

N Van den Berghe and others

Journal of Crohn's and Colitis, Volume 15, Issue Supplement_1, May 2021, Pages S338–S339, https://doi.org/10.1093/ecco-jcc/jjab076.435

Published: 27 May 2021

Journal Article

P601 Development and validation of dried blood spot sampling as a tool to identify the best time point to measure predictive ustekinumab serum concentrations in patients with Crohn’s disease

PDF

N Van den Berghe and others

Journal of Crohn's and Colitis, Volume 14, Issue Supplement_1, January 2020, Page S502, https://doi.org/10.1093/ecco-jcc/jjz203.729

Published: 15 January 2020

Journal Article

DOP46 Impact of a genetic burden on familial aggregation of inflammatory bowel disease

PDF

H S Lee and others

Journal of Crohn's and Colitis, Volume 14, Issue Supplement_1, January 2020, Page S085, https://doi.org/10.1093/ecco-jcc/jjz203.085

Published: 15 January 2020

Journal Article

P553 Safety of the sequential use of biological therapy in inflammatory bowel disease: Results from a tertiary referral centre

PDF

A Moens and others

Journal of Crohn's and Colitis, Volume 14, Issue Supplement_1, January 2020, Page S470, https://doi.org/10.1093/ecco-jcc/jjz203.681

Published: 15 January 2020

Journal Article

DOP31 Serum protein markers for early and differential IBD diagnosis validated by machine learning approaches

PDF

S Verstockt and others

Journal of Crohn's and Colitis, Volume 14, Issue Supplement_1, January 2020, Page S070, https://doi.org/10.1093/ecco-jcc/jjz203.070

Published: 15 January 2020

Journal Article

P827 Up-regulation of IL17-related pathways in affected colon from ulcerative colitis compared with Crohn’s disease Get access

PDF

S Verstockt and others

Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Pages S537–S538, https://doi.org/10.1093/ecco-jcc/jjy222.951

Published: 25 January 2019

Journal Article

DOP26 Biological therapy increases NCR+ ILC3 levels in IBD patients Get access

PDF

B Creyns and others

Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Page S040, https://doi.org/10.1093/ecco-jcc/jjy222.061

Published: 25 January 2019

Journal Article

P385 TREM1, the first anti-TNF specific biomarker guiding therapeutic decision Get access

PDF

B Verstockt and others

Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Page S300, https://doi.org/10.1093/ecco-jcc/jjy222.509

Published: 25 January 2019

Journal Article

P821 Distinct and common gene expression profiles between inflamed ileum and colon of newly diagnosed CD patients Get access

PDF

S Verstockt and others

Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Page S533, https://doi.org/10.1093/ecco-jcc/jjy222.945

Published: 25 January 2019

Journal Article

P042 Decreased leukocyte trafficking may contribute to vedolizumab refractory disease after anti-TNF exposure in patients with ulcerative colitis Get access

PDF

B Verstockt and others

Journal of Crohn's and Colitis, Volume 12, Issue supplement_1, February 2018, Page S113, https://doi.org/10.1093/ecco-jcc/jjx180.169